Cardiovascular pharmacogenetics-Reference-Cited by-同舟云学术

Cardiovascular pharmacogenetics

Published:2012-03 Issue:3 Volume:133 Page:280-290
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Myburgh Renier,Hochfeld Warren E.,Dodgen Tyren M.,Ker James,Pepper Michael S.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference140 articles.

1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles;Aklillu;J Pharmacol Exp Ther,1996

2. Cardiac sodium channel gene variants and sudden cardiac death in women;Albert;Circulation,2008

3. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity;Ameyaw;Pharmacogenetics,2001

4. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure;Andersson;J Am Coll Cardiol,1996

5. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease;Angiolillo;Thromb Res,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Gender Pharmacogenetics in the Personalization of Drug Treatment;Journal of Pharmacology and Experimental Therapeutics;2023-03-31

2. Pharmacogenetic polymorphisms affecting bisoprolol response;Biomedicine & Pharmacotherapy;2021-10

3. Pilot study in pharmacogenomic management of empagliflozin in type 2 diabetes mellitus patients;Journal of Diabetes & Metabolic Disorders;2021-08-10

4. Bisoprolol responses (PK/PD) in hypertensive patients: A cytochrome P450 (CYP) 2D6 targeted polymorphism study;Saudi Journal of Biological Sciences;2020-10

5. Sexual Dimorphism in Drug Metabolism and Pharmacokinetics;Current Drug Metabolism;2020-02-25